87 related articles for article (PubMed ID: 12673685)
1. CS-1, a novel c-kithi+ acute myeloid leukemia cell line with dendritic cell differentiation capacity and absent immunogenicity.
Erben U; Thiel E; Bittroff-Leben A; Schoch C; Fichtner I; Dürkop H; Notter M
Int J Cancer; 2003 Jun; 105(2):232-40. PubMed ID: 12673685
[TBL] [Abstract][Full Text] [Related]
2. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
Sheng LX; Xie XB; Qiu GQ; Gu WY; Wang ZL; Wu HQ
Ai Zheng; 2005 Nov; 24(11):1338-44. PubMed ID: 16552959
[TBL] [Abstract][Full Text] [Related]
3. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
Blair A; Sutherland HJ
Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
[TBL] [Abstract][Full Text] [Related]
4. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
5. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.
Vuckovic S; Abdul Wahid FS; Rice A; Kato M; Khalil D; Rodwell R; Hart DN
Exp Hematol; 2008 Nov; 36(11):1496-506. PubMed ID: 18715688
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
de Kroon JF; Kluin-Nelemans HC; Kluin PM; Schuuring E; van Bergen CA; Oving I; Wessels H; Willemze R; Falkenburg JH
Exp Hematol; 1997 Sep; 25(10):1062-8. PubMed ID: 9293903
[TBL] [Abstract][Full Text] [Related]
7. The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells.
Tsuchiya T; Hagihara M; Shimakura Y; Ueda Y; Gansuvd B; Munkhbat B; Inoue H; Tazume K; Kato S; Hotta T
Int J Hematol; 2002 Jan; 75(1):55-62. PubMed ID: 11843292
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion does not alter the capacity of umbilical cord blood CD34+ cells to generate functional T lymphocytes and dendritic cells.
Kobari L; Giarratana MC; Gluckman JC; Douay L; Rosenzwajg M
Stem Cells; 2006 Sep; 24(9):2150-7. PubMed ID: 16946001
[TBL] [Abstract][Full Text] [Related]
10. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
[TBL] [Abstract][Full Text] [Related]
11. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
Ramírez M; Rottman GA; Shultz LD; Civin CI
Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
[TBL] [Abstract][Full Text] [Related]
12. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
13. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
[TBL] [Abstract][Full Text] [Related]
15. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1.
Roddie PH; Horton Y; Turner ML
Leukemia; 2002 Jan; 16(1):84-93. PubMed ID: 11840267
[TBL] [Abstract][Full Text] [Related]
16. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
[TBL] [Abstract][Full Text] [Related]
18. Fusion of dendritic cells and CD34+CD38- acute myeloid leukemia (AML) cells potentiates targeting AML-initiating cells by specific CTL induction.
Lei Z; Zhang GM; Hong M; Feng ZH; Huang B
J Immunother; 2009 May; 32(4):408-14. PubMed ID: 19342964
[TBL] [Abstract][Full Text] [Related]
19. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]